| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis |
| 掲載誌名 | 正式名：Therapeutic Advances in Medical Oncology |
| 掲載区分 | 国外 |
| 著者・共著者 | Ikeda S, Ogura T, Kato T, Kenmotsu H, Iwasawa T, Misumi T, Yamanaka T, Okamoto H |
| 発行年月 | 2020 |